CDC – Page 4

Top CDC COVID vaccine expert resigns after RFK Jr. unilaterally restricts access

anti-vaccine, CDC, COVID-19, health, robert f kennedy jr, vaccines / Tim Belzer / June 4, 2025

A top expert at the Centers for Disease Control and Prevention who was overseeing the process to update COVID-19 vaccine recommendations resigned on Tuesday.

The resignation, first reported by The Associated Press and confirmed by CBS News, comes just a week after health secretary and anti-vaccine advocate Robert F. Kennedy Jr. unilaterally revoked and altered some of the CDC’s recommendations for COVID-19 vaccines, restricting access to children and pregnant people. The resignation also comes three weeks before CDC’s experts and advisors are scheduled to meet to publicly evaluate data and discuss the recommendations for this season—a long-established process that was disrupted by Kennedy’s announcement.

The departing CDC official, Lakshmi Panagiotakopoulos, a pediatric infectious disease expert, was a co-leader of a working group on COVID-19 vaccines who advised experts on the CDC’s Advisory Committee on Immunization Practices (ACIP). She informed her ACIP colleagues of her resignation in an email on Tuesday.

“My career in public health and vaccinology started with a deep-seated desire to help the most vulnerable members of our population, and that is not something I am able to continue doing in this role,” Panagiotakopoulos wrote.

Unilateral changes

Previously, the CDC and ACIP recommended COVID-19 vaccines for everyone ages 6 months and up. Experts have emphasized that pregnant people in particular should get vaccinated, as pregnancy suppresses the immune system and puts pregnant people at high risk of severe COVID-19 and death. The American College of Obstetricians and Gynecologists states that “COVID-19 infection during pregnancy can be catastrophic.” Further, dozens of studies have found that the vaccines are safe and effective at protecting the pregnant person, the pregnancy, and newborns.

Top CDC COVID vaccine expert resigns after RFK Jr. unilaterally restricts access Read More »

CDC updates COVID vaccine recommendations, but not how RFK Jr. wanted

CDC, centers for disease control and prevention, health, rfk jr, vaccines / Paul Patrick / May 31, 2025

In practice, it is unclear how this change will affect access to the vaccines. Health insurers are required to cover vaccines on the CDC schedules. But, it’s yet to be seen if children will only be able to get vaccinated at their doctor’s office (rather than a pharmacy or vaccine clinic) or if additional consent forms would be required, etc. Uncertainty about the changes and requirements alone may lead to fewer children getting vaccinated.

In the adult immunization schedule, when viewed “by medical condition or other indication” (table 2), the COVID-19 vaccination recommendation for pregnancy is now shaded gray, meaning “no guidance/not applicable.” Hovering a cursor over the box brings up the recommendation to “Delay vaccination until after pregnancy if vaccine is indicated.” Previously, COVID-19 vaccines were recommended during pregnancy. The change makes it less likely that health insurers will cover the cost of vaccination during pregnancy.

The change is at odds with Trump’s Food and Drug Administration, which just last week confirmed that pregnancy puts people at increased risk of severe COVID-19 and, therefore, vaccination is recommended. Medical experts have decried the loss of the recommendation, which is also at odds with clear data showing the risks of COVID-19 during pregnancy and the benefits of vaccination.

The President of the American College of Obstetricians and Gynecologists (ACOG) put out a statement shortly after the Tuesday video, saying that the organization was “extremely disappointed” with Kennedy’s announcement.

“It is very clear that COVID-19 infection during pregnancy can be catastrophic and lead to major disability, and it can cause devastating consequences for families,” ACOG President Steven Fleischman said.

CDC updates COVID vaccine recommendations, but not how RFK Jr. wanted Read More »

CDC can no longer help prevent lead poisoning in children, state officials say

applesauce, CDC, health, lead, Robert F. Kennedy / Rejus Almole / May 24, 2025

Amid the brutal cuts across the federal government under the Trump administration, perhaps one of the most gutting is the loss of experts at the Centers for Disease Control and Prevention who respond to lead poisoning in children.

On April 1, the staff of the CDC’s Childhood Lead Poisoning Prevention Program was terminated as part of the agency’s reduction in force, according to NPR. The staff included epidemiologists, statisticians, and advisors who specialized in lead exposures and responses.

The cuts were immediately consequential to health officials in Milwaukee, who are currently dealing with a lead exposure crisis in public schools. Six schools have had to close, displacing 1,800 students. In April, the city requested help from the CDC’s lead experts, but the request was denied—there was no one left to help.

In a Congressional hearing this week, US health secretary and anti-vaccine advocate Robert F. Kennedy Jr. told lawmakers, “We have a team in Milwaukee.”

But Milwaukee Health Commissioner Mike Totoraitis told NPR that this is false. “There is no team in Milwaukee,” he said. “We had a single [federal] staff person come to Milwaukee for a brief period to help validate a machine, but that was separate from the formal request that we had for a small team to actually come to Milwaukee for our Milwaukee Public Schools investigation and ongoing support there.”

Kennedy has also previously told lawmakers that lead experts at the CDC who were terminated would be rehired. But that statement was also false. The health department’s own communications team told ABC that the lead experts would not be reinstated.

CDC can no longer help prevent lead poisoning in children, state officials say Read More »

Under RFK Jr., COVID shots will only be available to people 65+, high-risk groups

anti-vaccine, boosters, CDC, COVID-19, fda, health, robert f kennedy jr, vaccines / Tim Belzer / May 21, 2025

FDA will require big, pricy trials for approvals for healthy kids and adults

U.S. Secretary of Health and Human Services Robert F. Kennedy Jr. testifies before the Senate Committee on Health, Education, Labor, and Pensions on Capitol Hill on May 20, 2025 in Washington, DC. Credit: Getty | Tasos Katopodis

Under the control of anti-vaccine advocate Robert F. Kennedy Jr., the Food and Drug Administration is unilaterally terminating universal access to seasonal COVID-19 vaccines; instead, only people who are age 65 years and older and people with underlying conditions that put them at risk of severe COVID-19 will have access to seasonal boosters moving forward.

The move was laid out in a commentary article published today in the New England Journal of Medicine, written by Trump administration FDA Commissioner Martin Makary and the agency’s new top vaccine regulator, Vinay Prasad.

The article lays out a new framework for approving seasonal COVID-19 vaccines, as well as a rationale for the change—which was made without input from independent advisory committees for the Food and Drug Administration and the Centers for Disease Control and Prevention.

Normally, the FDA’s VRBPAC (Vaccines and Related Biological Products Advisory Committee) and the CDC’s ACIP (Advisory Committee on Immunization Practices) would publicly review, evaluate, and discuss vaccine approvals and recommendations. Typically, the FDA’s scope focuses on licensure decisions, made with strong influence from VRBPAC, while the CDC’s ACIP is principally responsible for influencing the CDC’s more nuanced recommendations on usage, such as for specific age or risk groups. These recommendations shape clinical practice and, importantly, health insurance coverage.

Makary and Prasad appear to have foregone those norms, even though VRBPAC is set to meet this Thursday to discuss COVID-19 vaccines for the upcoming season.

Restrictions

In the commentary, Markary and Prasad puzzlingly argue that the previous universal access to COVID-19 vaccines was patronizing to Americans. They describe the country’s approach to COVID boosters as a “one-size-fits-all” and write that “the US policy has sometimes been justified by arguing that the American people are not sophisticated enough to understand age- and risk-based recommendations. We reject this view.”

Previously, the seasonally updated vaccines were available to anyone age 6 months and up. Further, people age 65 and older and those at high risk were able to get two or more shots, based on their risk. So, while Makary and Prasad ostensibly reject the view of Americans as being too unsophisticated to understand risk-based usage, the pair are installing restrictions to force their own idea of risk-based usage.

Even more puzzlingly, in an April meeting of ACIP, the expert advisors expressed clear support for shifting from universal recommendations for COVID-19 boosters to recommendations based on risk. Specifically, advisors were supportive of urging boosters for people age 65 and older and people who are at risk of severe COVID-19—the same restrictions that Makary and Prasad are forcing. The two regulators do not mention this in their NEJM commentary. ACIP would also likely recommend a primary series of seasonally matched COVID-19 vaccines for very young children who have not been previously exposed to the virus or vaccinated.

ACIP will meet again in June, but without a permissive license from the FDA, ACIP’s recommendations for risk-based usage of this season’s COVID-19 shots are virtually irrelevant. And they cannot recommend usage in groups that the FDA licensure does not cover. It’s unclear if a primary series for young children will be available and, if so, how that will be handled moving forward.

New vaccine framework

Under Makary and Prasad’s new framework, seasonally updated COVID-19 vaccines can continue to be approved annually using only immunology studies—but the approvals will only be for people age 65 and over and people who are at high risk. These immunology studies look at antibody responses to boosters, which offer a shorthand for efficacy in updated vaccines that have already been through rigorous safety and efficacy trials. This is how seasonal flu shots are approved each year and how COVID boosters have been approved for all people age 6 months and up—until now.

Moving forward, if a vaccine maker wants to have their COVID-19 vaccine also approved for use in healthy children and healthy adults under age 65, they will have to conduct large, randomized, placebo-controlled studies. These may need to include tens of thousands of participants, especially with high levels of immunity in the population now. These trials can easily cost hundreds of millions of dollars, and they can take many months to complete. The requirement for such trials will make it difficult, if not impossible, for drug makers to conduct them each year and within a timeframe that will allow for seasonal shots to complete the trial, get regulatory approval, and be produced at scale in time for the start of the respiratory virus season.

Makary and Prasad did not provide any data analysis or evidence-based reasoning for why additional trials would be needed to continue seasonal approvals. In fact, the commentary had a total of only eight references, including an opinion piece Makary published in Newsweek and a New York Times article.

“We simply don’t know whether a healthy 52-year-old woman with a normal BMI who has had COVID-19 three times and has received six previous doses of a COVID-19 vaccine will benefit from the seventh dose,” they argue in their commentary.

Their new framework does not make any mention of what will happen if a more dangerous SARS-CoV-2 variant emerges. It also made no mention of vaccine usage in people who are in close contact with high-risk groups, such as ICU nurses or family members of immunocompromised people.

Context

Another lingering question from the framework is how easy it will be for people deemed at high risk to get access to seasonal shots. Makary and Prasad lay out a long list of conditions that would put people at risk of severe COVID-19 and therefore make them eligible for a seasonal booster. The list includes: obesity; asthma; lung diseases; HIV; diabetes; pregnancy; gestational diabetes; heart conditions; use of corticosteroids; dementia; physical inactivity; mental health conditions, including depression; and smoking, current or former. The FDA leaders estimate that between 100 million and 200 million Americans will fit into the category of being at high risk. It’s unclear what such a large group of Americans will need to do to establish eligibility every year.

In all, the FDA’s move to restrict and hinder access to seasonal COVID-19 vaccines is in line with Kennedy’s influential anti-vaccine advocacy work. In 2021, prior to taking the role of the country’s top health official, Kennedy and the anti-vaccine organization he founded, Children’s Health Defense, petitioned the FDA to revoke authorizations for COVID-19 vaccines and refrain from issuing any approvals.

Ironically, Makary and Prasad blame the country’s COVID-19 policies for helping to erode Americans’ trust in vaccines broadly.

“There may even be a ripple effect: public trust in vaccination in general has declined, resulting in a reluctance to vaccinate that is affecting even vital immunization programs such as that for measles–mumps–rubella (MMR) vaccination, which has been clearly established as safe and highly effective,” the two write, including the most full-throated endorsement of the MMR vaccine the Trump administration has issued yet. Kennedy continues to spread misinformation about the vaccine, including the false and debunked idea that it causes autism.

“Against this context, the Food and Drug Administration seeks to provide guidance and foster evidence generation,” Makary and Prasad write.

Beth is Ars Technica’s Senior Health Reporter. Beth has a Ph.D. in microbiology from the University of North Carolina at Chapel Hill and attended the Science Communication program at the University of California, Santa Cruz. She specializes in covering infectious diseases, public health, and microbes.

Under RFK Jr., COVID shots will only be available to people 65+, high-risk groups Read More »

A dangerous E. coli strain has emerged; a small mutation may explain its rise

CDC, E. coli, effector, health, outbreak, Science, Type 3 secretion system / Kris Guyer / May 15, 2025

Small change

The CDC researchers identified the EspW mutation by comparing the genetic sequences of 729 isolates of the new E. coli strain—dubbed REPEXH01—to genetic sequences of 2,027 other E. coli O157:H7 isolates. Of the 729 REPEXH01 strains, all but two had a single nucleotide deletion in EspW (the remaining two had ambiguous sequences), while the deletion was present in less than 4 percent of the non-REPEXH01 E. coli strains. The finding suggests the tiny change could be a genetic signature of the strain, and its persistence in a key disease protein may offer the strain an advantage.

For now, it’s unclear what that advantage might be. The deletion of a single DNA base (an adenine) shifts the frame of the three-sequence protein code for the rest of EspW. This could result in a shorter protein. It could also cause the molecular machinery that translates the genetic code to slip, leading to proteins of various lengths. In any case, the deletion is likely to result in a less fully functional EspW protein.

The CDC researchers suggest this could help E. coli when it’s on lettuce and other produce. For example, EspW might spur an immune response from an infected plant that causes stomata—pores on the surfaces of leaves—to close, blocking the bacteria’s ability to invade. Thus, cutting back EspW may help E. coli sneak in—an adaptation in the ongoing arms race between the bacteria and its host. Another possibility is that EspW could function like HopW1, leading to more severe infection in plant tissues, which could lower the chances that those infected leaves are harvested and make it to grocery stores and atop burgers. Thus, cutting back on EspW could help E. coli move to its human victims.

Ultimately, additional research will be needed to understand what’s going on. As the CDC researchers conclude: “the role of the single base pair mutation in this strain’s colonization and survival on leafy vegetables could yield valuable insights.”

A dangerous E. coli strain has emerged; a small mutation may explain its rise Read More »

Texas goes after toothpaste in escalating fight over fluoride

cavities, CDC, fluoride, health, Oral health, texas, toothpaste, water / Paul Patrick / May 3, 2025

Texas Attorney General Ken Paxton is investigating two leading toothpaste makers over their use of fluoride, suggesting that they are “illegally marketing” the teeth cleaners to parents and kids “in ways that are misleading, deceptive, and dangerous.”

The toothpaste makers in the crosshairs are Colgate-Palmolive Company, maker of Colgate toothpastes, and Proctor & Gamble Manufacturing Co., which makes Crest toothpastes. In an announcement Thursday, Paxton said he has sent Civil Investigative Demands (CIDs) to the companies.

The move is an escalation in an ongoing battle over fluoride, which effectively prevents dental cavities and improves oral health. Community water fluoridation has been hailed by health and dental experts as one of the top 10 great public health interventions for advancing oral health across communities, regardless of age, education, or income. But, despite the success, fluoride has always had detractors—from conspiracy theorists in the past suggesting the naturally occurring mineral is a form of communist mind control, to more recent times, in which low-quality, controversial studies have suggested that high doses may lower IQ in children.

The debate was renewed earlier this year when the National Toxicology Program at the National Institute of Environmental Health Sciences finally published a particularly contentious study after years of failed scientific reviews. The study claims to find a link between high levels of fluoride exposure and slightly lower IQs in children living in areas outside the US, mostly in China and India. But the study’s methodology, statistical rigor, risk of bias, and lack of data transparency continue to draw criticism.

Texas goes after toothpaste in escalating fight over fluoride Read More »

With over 900 US measles cases so far this year, things are looking bleak

CDC, elimination, health, measles, MMR, vaccination / Rejus Almole / April 26, 2025

As of Friday, April 25, the US has confirmed over 900 measles cases since the start of the year. The cases are across 29 states, but most are in or near Texas, where a massive outbreak continues to mushroom in close-knit, undervaccinated communities.

On April 24, the Centers for Disease Control and Prevention had tallied 884 cases across the country. Today, the Texas health department updated its outbreak total, adding 22 cases to its last count from Tuesday. That brings the national total to at least 906 confirmed cases. Most of the cases are in unvaccinated children and teens.

Overall, Texas has identified 664 cases since late January. Of those, 64 patients have been hospitalized, and two unvaccinated school-aged children with no underlying medical conditions have died of the disease. An unvaccinated adult in New Mexico also died from the infection, bringing this year’s measles death toll to three.

The cases and deaths are breaking records. In the past 30 years, the only year with more measles cases than the current tally was 2019, which saw 1,274 cases. Most of those cases were linked to large, extended outbreaks in New York City that took 11 months to quell. The US was just weeks away from losing its elimination status, an achievement earned in 2000 when the country first went 12 months without continuous transmission.

Since 2019, vaccination coverage of the measles, mumps, and rubella (MMR) vaccine among US kindergartners has only fallen. National rates fell from 95 percent in 2019—the threshold considered necessary to keep measles from spreading—to 92.7 percent in the 2023–24 school year, the most recent year for which there’s data.

On the brink

In 2019, amid the record annual case tally, cases had only reached a total of 704 by April 26. With this year’s tally already over 900, the country is on track to record a new high. Before 2019, the next highest case total for measles was in 1994. That year, the country saw 899 cases, which 2025 has already surpassed.

With over 900 US measles cases so far this year, things are looking bleak Read More »

Controversial doc gets measles while treating unvaccinated kids—keeps working

anti-vaccine, CDC, children's health defense, health, measles, outbreak, robert f kennedy jr / Tim Belzer / April 22, 2025

In the video with Edwards that has just come to light, CHD once again uses the situation to disparage MMR vaccines. Someone off camera asks Edwards if he had never had measles before, to which he replies that he had gotten an MMR vaccine as a kid, though he didn’t know if he had gotten one or the recommended two doses.

“That doesn’t work then, does it?” the off-camera person asks, referring to the MMR vaccine. “No, apparently not, ” Edwards replies. “Just wear[s] off.”

It appears Edwards had a breakthrough infection, which is rare, but it does occur. They’re more common in people who have only gotten one dose, which is possibly the case for Edwards.

A single dose of MMR is 93 percent effective against measles, and two doses are 97 percent effective. In either case, the protection is considered lifelong.

While up to 97 percent effectiveness is extremely protective, some people do not mount protective responses and are still vulnerable to an infection upon exposure. However, their illnesses will likely be milder than if they had not been vaccinated. In the video, Edwards described his illness as a “mild case.”

The data on the outbreak demonstrates the effectiveness of vaccination. As of April 18, Texas health officials have identified 597 measles cases, leading to 62 hospitalizations and two deaths in school-aged, unvaccinated children with no underlying medical conditions. Most of the cases have been in unvaccinated children. Of the 597 cases, 12 (2 percent) had received two MMR doses previously, and 10 (1.6 percent) had received one dose. The remaining 96 percent of cases are either unvaccinated or have no record of vaccination.

Toward the end of the video, Edwards tells CHD he’s “doing what any doctor should be doing.”

Controversial doc gets measles while treating unvaccinated kids—keeps working Read More »

“Lab leak” marketing page replaces federal hub for COVID resources

CDC, COVID-19, health, Lab leak, SARS-CoV-2, Trump / Tim Belzer / April 19, 2025

After obliterating the federal office on long COVID and clawing back billions in COVID funding from state health departments, the Trump administration has now entirely erased the online hub for federal COVID-19 resources. In its place now stands a site promoting the unproven idea that the pandemic virus SARS-CoV-2 was generated in and leaked from a lab in China, sparking the global health crisis.

Navigating to COVID.gov brings up a slick site with rich content that lays out arguments and allegations supporting a lab-based origin of the pandemic and subsequent cover-up by US health officials and Democrats.

Previously, the site provided unembellished quick references to COVID-19 resources, including links to information on vaccines, testing, treatments, and long COVID. It also provided a link to resources for addressing COVID-19 vaccine misconceptions and confronting misinformation. That all appears to be gone now, though some of the same information still remains on a separate COVID-19 page hosted by the Centers for Disease Control and Prevention.

While there remains no definitive answer on how the COVID-19 pandemic began, the scientific data available on the topic points to a spillover event from a live wild animal market in Wuhan, China. The scientific community largely sees this as the most likely scenario, given the data so far and knowledge of how previous outbreak viruses originated, including SARS-CoV-1. By contrast, the lab origin hypothesis largely relies on the proximity of a research lab to the first cases, conjecture, and distrust of the Chinese government, which has not been forthcoming with information on the early days of the health crisis. Overall, the question of SARS-CoV-2’s origin has become extremely politicized, as have most other aspects of the pandemic.

“Lab leak” marketing page replaces federal hub for COVID resources Read More »

CDC struggling to fight raging measles outbreak after deep funding, staff cuts

ACIP, CDC, health, measles, MMR, outbreak, vaccination / Rejus Almole / April 17, 2025

In now-rarified comments from experts at the Centers for Disease Control and Prevention, an agency official on Tuesday evening said the explosive measles outbreak mushrooming out of West Texas will require “significant financial resources” to control and that the agency is already struggling to keep up.

“We are scrapping to find the resources and personnel needed to provide support to Texas and other jurisdictions,” said David Sugerman, the CDC’s lead on its measles team. The agency has been devastated by brutal cuts to CDC staff and funding, including a clawback of more than $11 billion in public health funds that largely went to state health departments.

Sugerman noted that the response to measles outbreaks is generally expensive. “The estimates are that each measles case can be $30,000 to $50,000 for public health response work—and that adds up quite quickly.” The costs go to various responses, including on-the-ground response teams, vaccine doses and vaccination clinics, case reporting, contact tracing, mitigation plans, infection prevention, data systems, and other technical assistance to state health departments.

In the past, the CDC would provide media briefings and other public comments on the responses to such an extraordinarily large and fast-moving outbreak. However, Sugerman’s comments are among the first publicly made by CDC experts under the current administration. He spoke about the outbreak at the very end of an all-day public meeting of the agency’s Advisory Committee on Immunization Practices (ACIP), which discussed a broad range of vaccine and vaccine-preventable diseases over the course of the day.

The meeting was initially planned for February but was abruptly canceled and then rescheduled upon the Trump administration coming into office, including the new health secretary and longtime anti-vaccine advocate, Robert F. Kennedy, Jr. But, despite concern for ACIP’s future, the meeting proceeded more or less as usual on Tuesday and continues today with additional topics. The last 30 minutes of yesterday’s agenda was set aside for an update on the measles outbreak.

“I find it absolutely devastating that we’re having this update today,” ACIP chair Keipp Talbot said at the outset of Sugerman’s update. “There’s no reason why we have healthy children dying of measles in the US when this vaccine is amazing,” Talbot said, referencing the measles, mumps, and rubella (MMR) vaccine. “It’s highly effective and has very long-lasting immunity.” Two doses of MMR offer 97 percent protection against the virus, which is among the most infectious viruses known.

CDC struggling to fight raging measles outbreak after deep funding, staff cuts Read More »

Autism rate rises slightly; RFK Jr. claims he’ll “have answers by September“

autism, CDC, health, robert f kennedy jr, Testing / Paul Patrick / April 16, 2025

Among the sites, there were large differences. Prevalence ranged from 9.7 per 1,000 children who were 8 years old in Texas (Laredo) to 53.1 in California. These differences are likely due to “differences in availability of services for early detection and evaluation and diagnostic practices,” the CDC and network researchers wrote.

For instance, California—the site with the highest prevalence among 8-year-olds and also 4-year-olds—has a local initiative called the Get SET Early model. “As part of the initiative, hundreds of local pediatricians have been trained to screen and refer children for assessment as early as possible, which could result in higher identification of ASD, especially at early ages,” the authors write. “In addition, California has regional centers throughout the state that provide evaluations and service coordination for persons with disabilities and their families.”

On the other hand, the low ASD rates at the network’s two Texas sites could “suggest lack of access or barriers to accessing identification services,” the authors say. The two Texas sites included primarily Hispanic and lower-income communities.

The newly revealed higher rates in some of the network’s underserved communities could link ASD prevalence to social determinants of health, such as low income and housing and food insecurity, the authors say. Other factors, such as higher rates of preterm birth, which is linked to neurodevelopmental disabilities, as well as lead poisoning and traumatic brain injuries, may also contribute to disparities.

Anti-vaccine voices

The detailed, data-heavy report stands in contrast to the position of health secretary Robert F. Kennedy Jr., a longtime anti-vaccine advocate who promotes the false and thoroughly debunked claim that autism is caused by vaccines. Last month, Kennedy hired the discredited anti-vaccine advocate David Geier to lead a federal study examining whether vaccines cause autism, despite numerous high-quality studies already finding no link between the two.

Geier, who has no medical or scientific background, has long worked with his father, Mark Geier, to promote the idea that vaccines cause autism. In 2011, Mark Geier was stripped of his medical license for allegedly mistreating children with autism, and David Geier was fined for practicing medicine without a license.

In a media statement Tuesday in response to the new report, Kennedy called autism an “epidemic” that is “running rampant.” He appeared to reference his planned study with Geier, saying: “We are assembling teams of world-class scientists to focus research on the origins of the epidemic, and we expect to begin to have answers by September.”

Autism rate rises slightly; RFK Jr. claims he’ll “have answers by September“ Read More »

RFK Jr.‘s bloodbath at HHS: Blowback grows as losses become clearer

CDC, CMS, fda, health, HHS, NIH, robert f kennedy jr, trump administration / Mike M. / April 3, 2025

Last week, Health Secretary and anti-vaccine advocate Robert F. Kennedy Jr. announced the Trump administration would hack off nearly a quarter of employees at the Department of Health and Human Services, which oversees critical agencies including the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH), and the Centers for Medicare and Medicaid Services (CMS).

The downsizing includes pushing out about 10,000 full-time employees through early retirements, deferred resignations, and other efforts. Another 10,000 will be laid off in a brutal restructuring, bringing the total HHS workforce from 82,000 to 62,000.

“This will be a painful period,” Kennedy said in a video announcement last week. Early yesterday morning, the pain began.

It begins

At the FDA—which will lose 3,500 employees, about 19 percent of staff—some employees learned they were being laid off from security guards after their badges no longer worked when they showed up to their offices, according to Stat. At CMS—which will lose 300 employees, about 4 percent—laid-off employees were instructed to file any discrimination complaints they may have with Anita Pinder, identified as the director of CMS’s Office of Equal Opportunity and Civil Rights. However, Pinder died last year, The Washington Post noted.

At the NIH—which is set to lose 1,200 employees, about 6 percent—new director Jay Bhattacharya sent and email to staff saying he would implement new policies “humanely,” while calling the layoffs a “significant reduction.” Five NIH institute directors and at least two other senior leaders have been ousted, in addition to hundreds of lower-level employees. Bhattacharya wrote that the remaining staff will have to find new ways to carry out “key NIH administrative functions, including communications, legislative affairs, procurement, and human resources.”

At CDC—which will lose 2,400 employees, about 18 percent—the cuts slashed employees working in chronic disease prevention, sexually transmitted diseases, HIV, tuberculosis, global health, environmental health, occupational safety and health, maternal and child health, birth defects, violence prevention, health equity, communications, and science policy.

Some leaders and workers at the CDC and NIH were reportedly reassigned or offered transfers to work at the Indian Health Services (IHS), an HHS division that provides medical and health services to Native American tribes. The transfers, which could require employees to move to a remote branch, are seen as another way to force workers out.

RFK Jr.‘s bloodbath at HHS: Blowback grows as losses become clearer Read More »